CBAV Clínica Baviera, S.A.

61.64USD56.20 EUR · BME0.00%Mkt Cap: 988.23M USDP/E: 19.58

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal dise…

Key Statistics

Company
Market Cap988.23M USD
Enterprise Value1.02B USD
Revenue (TTM)351.72M USD
Gross Profit293.73M USD
Net Income (TTM)46.13M USD
Revenue/Share21.97 USD
Last Price61.64 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.0K
CountryES
SectorHealthcare
IndustryDiagnostics & Research
ISINES0119037010
Valuation
P/E (Trailing)19.58
P/E (Forward)31.82
PEG2.70
EV/EBITDA10.50
EV/Revenue2.91
P/S2.80
P/B8.05
EPS (TTM)3.15 USD
EPS (Forward)1.93 USD
52W Range
44.0973% of range68.00
52W High68.00 USD
52W Low44.09 USD
Profitability
Gross Margin88.74%
Oper. Margin20.14%
EBITDA Margin27.68%
Profit Margin13.94%
ROE38.24%
ROA16.99%
ROIC33.02%
ROCE32.59%
Growth
Revenue Growth13.30%
Earnings Growth38.70%
Cash Flow & Leverage
Operating CF84.28M USD
CapEx (TTM)32.92M USD
FCF Margin13.24%
FCF Yield4.71%
Net Debt21.74M USD
Net Debt/EBITDA0.22
Net Debt/FCF0.47
Balance Sheet
Debt/Equity0.64
Current Ratio0.94
Quick Ratio0.86
Book Value/Sh7.63 USD
Cash/Share3.48 USD
Dividends
Fwd Div Rate1.72 USD
Trail. Div Rate1.72 USD
Div. Yield2.78%
5Y Avg Yield4.05%
Payout Ratio54.70%
Ex-Div DateJun 10, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.16.03M
Float3.02M
Insiders81.55%
Institutions11.60%
Technical
SMA 5060.11 (+2.5%)
SMA 20060.48 (+1.9%)
Beta0.80
S&P 52W Chg12.00%
Avg Vol (30d)1.63K
Avg Vol (10d)2.53K
Technical Indicators
RSI (14)64.1
MACD0.0954
MACD Signal-0.4457
MACD Hist.+0.5411
BB Upper61.61 USD
BB Middle58.69 USD
BB Lower55.77 USD
BB Width9.93%
ATR (14)1.494 USD
Vol Ratio (20d)1.06x

About Clínica Baviera (BME: CBAV)

›

Clínica Baviera (BME: CBAV) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 2,009 employees.

The shares were at 56.20 EUR on 19 November 2026, up 38.4% over 52 weeks. Its 52-week range is 40.20 EUR to 62.00 EUR: the price is 9.4% below the high and 39.8% above the low.

At a market capitalisation of 901.01M EUR, it trades at 19.6 times trailing earnings and 31.8 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 45% for CBAV. It pays a dividend yielding 2.78% (it pays out 55% of its earnings), against a median of 0.73% among the dividend payers in that peer group.

Clínica Baviera reports return on equity of 38.2%, an operating margin of 20.1% and revenue up 13.3% year over year.

Its debt exceeds its cash by 19.82M EUR, a debt-to-equity ratio of 0.64. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health.